Sanofi Genzyme competitorsClear all

Sanofi Genzyme's top competitors include Biogen, Amgen, Amicus Therapeutics and Portola Pharmaceuticals.
Sanofi Genzyme
Sanofi Genzyme
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Portola Pharmaceuticals
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company.
Founding Date
Founding Date
1981
Founding Date
1978
Founding Date
1980
Founding Date
2002
Founding Date
2003
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Macquarie Park, AU
Malaga, AU
Virginia, AU
São Paulo, BR
Mississauga, CA
Toronto, CA
see more
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paulo, BR
Mississauga, CA
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Kew, AU
North Ryde, AU
Wien, AT
Machelen, BE
see more
Locations
Cranbury Township, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin 15, IE
Milano, IT
see more
Locations
South San Francisco, US HQ
Krailling, DE
Amsterdam, NL
Employees
Employees
9,961
Employees
7,4005% decrease
Employees
23,4009% increase
Employees
58415% increase
Employees
32429% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
37.3 b
Valuation ($)
128.3 b
Valuation ($)
5.7 b
Valuation ($)
1.4 b
Twitter followers
Twitter followers
58.3 k
Twitter followers
35.2 k
Twitter followers
95 k
Twitter followers
1.7 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
20
Number of tweets (last 30 days)
52
Number of tweets (last 30 days)
91
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
26
Average likes per tweet (last 30 days)
14.7
Average likes per tweet (last 30 days)
13.6
Average likes per tweet (last 30 days)
2.9
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
85.71%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
367812
Alexa Website Rank
254464
Alexa Website Rank
181510
Alexa Website Rank
304877
Alexa Website Rank
251077
Employee Rating
Employee Rating
N/A
Employee Rating
4
Employee Rating
3.8
Employee Rating
3
Employee Rating
3.4

Financial

Revenue (est.)
Revenue (est.)
€10.4b (FY, 2019)
Revenue (est.)
$14.4b (FY, 2019)
Revenue (est.)
$23.4b (FY, 2019)
Revenue (est.)
$182.2m (FY, 2019)
Revenue (est.)
$116.6m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
$2b (FY, 2019)
Cost of goods
$4.4b (FY, 2019)
Cost of goods
$22m (FY, 2019)
Cost of goods
$44.4m (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
$12.4b (FY, 2019)
Gross profit
$19b (FY, 2019)
Gross profit
$160.3m (FY, 2019)
Gross profit
$72.3m (FY, 2019)
Net income
Net income
N/A
Net income
$5.9b (FY, 2019)
Net income
$7.8b (FY, 2019)
Net income
($356.4m) (FY, 2019)
Net income
($290.7m) (FY, 2019)

Operating

Countries
Countries
100 (Nov, 2020)
Countries
N/A
Countries
100 (FY, 2019)
Countries
N/A
Countries
N/A
Patents (US)
Patents (US)
605 (Nov, 2020)
Patents (US)
21 (FY, 2019)
Patents (US)
34 (FY, 2019)
Patents (US)
N/A
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
11 (Q2, 2020)
Phase I Trials Products
22 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
10 (Q2, 2020)
Phase II Trials Products
4 (FY, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
6 (Q2, 2020)
Phase III Trials Products
14 (Feb, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 175.5m
Total funding raised
$ 88m
Total funding raised
$ 295.1m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,400↓ 5% decrease

Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
Amgen
HQ
Thousand Oaks, US
Employees
23,400↑ 9% increase

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company
Amicus Therapeutics
HQ
Cranbury Township, US
Employees
584↑ 15% increase

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company
Portola Pharmaceuticals
HQ
South San Francisco, US
Employees
324↑ 29% increase

Portola Pharmaceuticals is a biopharmaceutical company.

View company